Sign in

CIK 0001832038

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Invivyd, Inc.

Sign in to watch
Ticker
IVVD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851403134
Phone
+1 781-819-0080
Business address
205 CHURCH STREET, NEW HAVEN, CT
Former names
Adagio Therapeutics, Inc.
  1. 4 Planned sale Chief Legal Officer, Secretary sold 67,710 shares at an average $1.56 ($105,581)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 50,000 shares at $2.50 ($125,000)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Chief Commercial Officer sold 49,656 shares at an average $0.60 ($29,808)
  11. 4 Planned sale Chief Financial Officer sold 49,656 shares at an average $0.60 ($29,808)
  12. 4 Planned sale Chief Human Resources Officer sold 49,656 shares at an average $0.60 ($29,808)
  13. 4 Planned sale Chief Legal Officer, Secretary sold 82,754 shares at an average $0.60 ($49,677)
  14. 4 Planned sale Chief Scientific Officer sold 45,932 shares at an average $0.60 ($27,573)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 165 filings